Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Advanced Breast Cancer × toripalimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Nasopharyngeal Carcinoma 19 Triple Negative Breast Neoplasms 11 Breast Neoplasms 10 Carcinoma, Non-Small-Cell Lung 8 Squamous Cell Carcinoma of Head and Neck 6 Advanced Solid Tumor 6 Neoplasms 5 Head and Neck Neoplasms 5 Uterine Cervical Neoplasms 4 Stomach Neoplasms 4 Esophageal Squamous Cell Carcinoma 4 Colorectal Neoplasms 4 Carcinoma, Transitional Cell 4 Solid Tumor 3 Small Cell Lung Carcinoma 3 Recurrence 3 Rectal Neoplasms 3 Esophageal Neoplasms 3 Carcinoma, Renal Cell 3 Sarcoma 2 Ovarian Neoplasms 2 Oropharyngeal Neoplasms 2 Neoplasm Metastasis 2 Nasopharyngeal Neoplasms 2 Microsatellite Stable Metastatic Colorectal Cancer 2 Melanoma 2 Locally Advanced Rectal Cancer 2 Liposarcoma 2 Laryngeal Neoplasms 2 Gestational Trophoblastic Disease 2

Interventions

Fulvestrant 4 trastuzumab deruxtecan 2 elacestrant 2 Vinorelbine 2 toripalimab 1 talazoparib 1 ribociclib 1 pyrotinib 1 palbociclib 1 olaparib 1 exemestane 1 eribulin 1 disitamab vedotin 1 dalpiciclib 1 apatinib 1 abemaciclib 1 Selective Estrogen Receptor Modulators 1 Ritonavir 1 Radiotherapy 1 RAD1901 1 Letrozole 1 Itraconazole 1 Injections 1 Gonadotropin-Releasing Hormone 1 Everolimus 1 Capecitabine 1 Aromatase Inhibitors 1 Anastrozole 1 Ado-Trastuzumab Emtansine 1 AZD9833 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07540533 2026-04-20

2025-370

Henan Cancer Hospital

Phase 2 Recruiting

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡